I do believe this is a good move in the grand scheme of things; but I can't say I didn't sweat a bit when I learned of the news...
There are few things that I don't understand that I hope those more experienced than I can illuminate on-
1.If getting libi was Simes' goal, why take an exit with this merger? As a Research Scientist in a past life, I find it's not a simple thing to let go of a project that you've spent a large part of your career studying...It seems in this deal, he's basically walking away. Could it be that the board didn't like his management of things thus far and decided to have a change in leadership?
2.With that said, if layoffs are occurring (or will occur if merger goes through) to what purpose does this serve in regards to continuing libigel? I would think dismissing those involved in the r/d up to date and handing the reigns over to ANIP is going to slow development; in the same breath, ANIP is not R/D they're manufacturing...which, as nutsy pointed out, should speak volumes as to where they are at with Libigel and if this is indeed the case, why all the bloody silence about it...
3.All the actions of Tang over the course of this year still warrant investigation because at this point, I think they're in the same position all of us are...or could it be they took the position they did to influence/hasten this merger?
I may have overlooked the answers in the recent filings but if anyone has any thoughts, it would be greatly appreciated if you could share them.
-RG
